Johnson & Johnson’s Janssen business unit just released its 2017 Janssen U.S. Transparency Report. (Free download.) This is the second annual edition of the report, which provides a comprehensive look at Janssen’s commercial activities. Most notably, Janssen reveals that the list price for its pharmaceutical products grew by 8.1% in 2017. Show More Summary
The calendar says that it will be Spring next week, but it did not feel like it to me while working in the cold, windy and rainy garden in the days leading up to this change in season. However, it … Continue reading ?
Below is our exclusive Drug Channels Institute list of the 15 largest pharmacies, ranked by estimated 2017 revenues from dispensing specialty pharmaceuticals. The battle for control of the specialty market accelerated in 2017, though pharmacies owned by pharmacy benefit managers (PBMs) continued to capture most of the market share. Show More Summary
Did I just hear the gross-to-net bubble deflate a little bit? This week, UnitedHealthcare announced that it would provide point-of-sale (POS) rebates to 7 million people enrolled in its fully insured commercial group benefit plans. Click...Show More Summary
Another busy week – tried and failed to squeeze in a posting between the Weekly Roundup, but am well set up for next week. The Northeast had another Nor’easter. And yet here we are once again ready to Spring Ahead … Continue reading...
PLOS Medicine, PLOS Computational Biology and PLOS ONE are excited to announce a cross-journal Call for Papers for high-quality research that applies or develops machine learning methods for improvement of human health. The team of Guest
CBI’s Real-Time Benefit Check & ePrior Authorization SummitMay 15-16, 2018 | Philadelphia, PAwww.cbinet.com/epriorJoin industry pioneers from bio/pharma, PBMs, payers, health systems, prescribers and system solutions providers at the...Show More Summary
Top 'o the morning to you! Let’s take a wee look at the Pharmacy Benefit Management Institute’s (PBMI) new 2018 Trends in Specialty Drug Benefits. (Free download with registration.) It’s a great resource for understanding how plan sponsors...Show More Summary
2nd Annual MSL Management & Development SummitMay 21-22, 2018 | Philadelphia, PAwww.worldcongress.com/msl Join senior medical affairs, medical science liaisons (MSLs), regulatory and communication professionals from life sciences organizations...Show More Summary
Wow. Yesterday, Cigna announced that it would acquire Express Scripts. See the links below. Though Cigna was an unexpected acquirer, the deal confirms the importance of pharmacy and medical benefit integration. It also reinforces the role that pharmacy benefit management (PBM) plays in the drug channel. Show More Summary
2nd Annual Manufacturers’ 340B SummitMay 15-16, 2018 | Philadelphia, PAwww.worldcongress.com/manufacturers340BJoin pharmaceutical manufacturers, legal experts, thought leaders, and leading regulatory strategists at World Congress’ 2nd Annual Manufacturers’ 340B Summit, May 16-17, in Philadelphia. Show More Summary
There would seem to be a momentum for new approvals brought on by a number of circumstances, not the least of which is the fact that last year saw a record number (47) of approvals for new molecular entities (NMEs), … Continue readi...
Senior Editor Amy Ross discusses the content published in week 1 of the PLOS Medicine Special Issue on CVD and Multimorbidity. This week, publication of a Special Issue on Cardiovascular Disease (CVD) and Multimorbidity begins
Last week, the Senate Judiciary Committee held an uneventful hearing on the CVS-Aetna merger. The lack of fireworks suggests that the deal is on track for approval later this year. Click here to read the testimony. Below, I review 2017...Show More Summary
Spring is definitely springing early. Buds are popping everywhere here in the mid-Atlantic region. Heck in some places, they are more than buds, they are blossoms. Still, the flu season drags on and this week Commissioner Gottlieb mentioned that it … Continue reading ?
In the last installment we looked at the first part of the Strategic Roadmap – Addiction which specifically focused on opioids and nicotine. However, the next part of the FDA Strategic Policy Roadmap is less specific and instead is focused … Continue reading ?
I am pleased to announce our new our 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, available for purchase and immediate download. Click here to download a free report overview (including the Table of Contents...Show More Summary
CBI’s 2nd Annual Drug Pricing Transparency CongressMarch 22, 2018 | Philadelphia, PAwww.cbinet.com/drugpricingOn the heels of an incredibly successful event last year, CBI is pleased to announce that its Drug Pricing Transparency Congress...Show More Summary
Two announcements last week were in startling contrast. One was a scientific development that moves the needle forward, the other a policy announcement that tries to pull it back. The first development came from Google AI researchers and a published … Continue reading ?
At least here in the mid-Atlantic region, the ground hog appears to have got it wrong, with a week that had quite moderate temperatures. In the herb garden, the chives have popped up, always a harbinger of Spring. I tried … Continue reading ?